KV Pharmaceutical, Purdue Pharma settle painkiller patent dispute - South Florida Business Journal:

ogarawo.wordpress.com
Under the settlement, KV agreed to no longer dispute the enforceabilityor infringement” of the Purdue generi oxycodone patents. In return, Purdue granted KV a limited, non-exclusives license to manufactureand sell, in the United a certain amount of varioua dosage strengths of the drugsz as long as KV pays royalties to Purdue. KV also reache a deal to be an authorized, non-exclusiv e distributor in the United States of certain generic versionasof OxyContin. These agreements settle threre patent infringementlawsuits Stamford, Conn.-based Purdue filex against KV in 2007. KV still faces more lawsuits from other companies, consumers and shareholders. Three individuals in St.
Clair Countuy Circuit Court against KV, alleging that certain drugas contained a potentially lethal amount of morphinse due to oversized tablets that were eventually recallecd by thepharmaceutical company. Last month, , a Florida-based dermatologyu company, sued KV, of a patenty for Duac topical gel, an acne KV also faces lawsuits from shareholders about manufacturing compliances andthe company’s financial prospects. Brentwood, Mo.-basecd KV has and recalled painkillers. In March, KV said it with the FDA that outlineas a series of measures that will permit KV and its subsidiaries to resume manufacturingand distribution.